Back to home » Treatment News » September 2007
September 19, 2007
New Data Explores Current Treatment Options
At the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Peter Staley asks Dr. Joe Eron about the good news on a challenging drug – newly-approved Selzentry – and the very potent new protease inhibitor, Prezista.
Scroll down to comment on this story.
Name:
(will display; 2-50 characters)
Email:
(will NOT display)
City:
(will display; optional)
Comment (500 characters left):
(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)
| Posting Rules
Previous Comments: